Indaptus Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -1.57%
- Market cap
- $418.38M
- 133.24M shares
- Filings
- 345
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2021derived
—Q3 2026N/M FY25 yoy
Q3 2026+47.0% FY25 yoy
- $418.38M
- —
- —
- 40.5×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $9,340,959 | reported | |
| FY 2024 | 2024-12-31 | $7,251,097 | reported | |
| FY 2023 | 2023-12-31 | $7,621,707 | reported | |
| FY 2022 | 2022-12-31 | $6,324,657 | reported | |
| FY 2021 | 2021-12-31 | $2,523,153 | reported | |
| FY 2020 | 2020-12-31 | $2,655,017 | reported |
Pharmaceutical preparations
Indaptus Therapeutics, Inc. is the 203rd largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RLMDRelmada Therapeutics, Inc.———$444.9MAVTXAvalo Therapeutics, Inc.$59.0K86.6%132,642.4%$444.4MCTMXCytomX Therapeutics, Inc.$76.2M44.8%22.8%$442.5MASMBAssembly Biosciences, Inc.$72.3M153.5%8.5%$431.6MCRMDCorMedix Inc.$311.7M617.0%52.3%$427.6MMPLTMapLight Therapeutics, Inc.———$422.5MPRTAProthena Corp Public Ltd Co$9.7M92.8%2,520.6%$422.1M
INDPIndaptus Therapeutics, Inc. (this company)———$418.4M
PBYIPuma Biotechnology, Inc.$228.4M0.9%13.6%$418.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR